Cite

HARVARD Citation

    Mayanagi, S. et al. (n.d.). Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Cancer science. 106 (4), pp. 397-406. [Online]. 
  
Back to record